AAVXF
Abivax S.A.
Key Financials
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| S-8 | 3/23/2026 | View on SEC |
| 20-F | 3/23/2026 | View on SEC |
| 6-K | 3/23/2026 | View on SEC |
| 6-K | 2/23/2026 | View on SEC |
| SCHEDULE 13G/A | 2/13/2026 | View on SEC |
| SCHEDULE 13D/A | 1/14/2026 | View on SEC |
| 144 | 1/8/2026 | View on SEC |
| 6-K | 12/15/2025 | View on SEC |
| SCHEDULE 13G/A | 11/14/2025 | View on SEC |
| SCHEDULE 13G/A | 11/14/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | AAVXF |
| Company Name | Abivax S.A. |
| CIK | 1956827 |
| Sector | Pharmaceutical Preparations |
| Industry | Accelerated filer Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | other |
| Fiscal Year End | 1231 |
| State of Incorporation | I0 |
| Phone | 01 53 83 09 63 |